ExemesMED 25 by Medi Pharma: aromatase inhibitor for estrogen control
Exemestane, sold as ExemesMED 25 by Medi Pharma, is a potent oral aromatase inhibitor (AI) that permanently binds to and deactivates the aromatase enzyme, reducing circulating estrogen levels. It is primarily used during steroid cycles to prevent estrogen-related side effects such as gynecomastia and water retention.
Key benefits
- Powerful estrogen reduction: Suicidal (irreversible) aromatase inhibition effectively lowers estrogen levels.
- Prevents gynecomastia: Eliminates the primary cause of male breast tissue development during cycles.
- Reduces water retention: Helps achieve a dry, vascular look during cutting phases.
- Improves testosterone-to-estrogen ratio: Supports a more favourable hormonal environment for muscle growth.
- Boosts natural testosterone: May mildly stimulate endogenous testosterone production.
Potential side effects
- Joint pain: Low estrogen levels may cause dry, aching joints.
- Reduced libido: Over-suppression of estrogen may negatively impact sex drive.
- Mood changes: May affect mood and emotional well-being.
- Bone density: Prolonged use may weaken bones; cycling is recommended.
Conclusion
ExemesMED 25 by Medi Pharma is a powerful aromatase inhibitor for estrogen management during anabolic cycles. Proper dosing and monitoring prevent over-suppression of estrogen.